Hutchison China Meditech Share Price Today
(NASDAQ: HCM)

Name: Hutchison China Meditech Share Price Today (NASDAQ: HCM) - Hutchison China Meditech Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Hutchison China Meditech share price is $13.76 & ₹1,176.27 as on 18 Apr 2025, 2.30 'hrs' IST

$13.76

▲

0.02

(0.15%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Hutchison China Meditech share price in Dollar and Rupees. Guide to invest in Hutchison China Meditech stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Hutchison China Meditech, along with analyst recommendations, forecasts, and comprehensive financials.

Hutchison China Meditech share price movements

Today's Low: $13.73
Today's High: $13.98
$13.76
0.22%
Downside
Day's Volatility :1.79%
Upside
1.57%
52 Weeks Low: $11.51
52 Weeks High: $21.92
$13.76
16.39%
Downside
52 Weeks Volatility :47.51%
Upside
37.23%

Hutchison China Meditech (HCM) Returns

Period	Hutchison China Meditech Limited	Sector (Health Care)	Index (Russel 2000)
3 Months	-3.24%	-1.8%	0.0%
6 Months	-34.26%	-10.1%	0.0%
1 Year	-16.01%	-0.5%	0.0%
3 Years	-20.94%	0.4%	-11.1%

Hutchison China Meditech (HCM) Key Statistics

in dollars & INR

Previous Close	$13.74
Open	$13.78
Today's High	$13.98
Today's Low	$13.73
Market Capitalization	$2.5B
Today's Volume	$34.2K
52 Week High	$21.92
52 Week Low	$11.505
Revenue TTM	$630.2M
EBITDA	$-31.4M
Earnings Per Share (EPS)	$0.2
PE Ratio	68.7
Profit Margin	5.99%
Quarterly Earnings Growth YOY	-0.84%
Return On Equity TTM	5.04%

How to invest in Hutchison China Meditech Stock (HCM) from India?

It is very easy for Indian residents to invest directly in Hutchison China Meditech from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Hutchison China Meditech stock in both Indian Rupees (INR) and US Dollars (USD). Search for Hutchison China Meditech or HCM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Hutchison China Meditech or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Hutchison China Meditech shares which would translate to 0.062 fractional shares of Hutchison China Meditech as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Hutchison China Meditech, in just a few clicks!

Returns in Hutchison China Meditech (HCM) for Indian investors in Rupees

The Hutchison China Meditech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Hutchison China Meditech investment value today

Current value as on today

₹86,451

Returns

₹13,549

(-13.55%)

Returns from Hutchison China Meditech Stock

₹15,892 (-15.89%)

Dollar Returns

₹2,343 (+2.34%)

Indian investors sentiment towards Hutchison China Meditech (HCM)

160.71%

Period: Mar 18, 2025 to Apr 17, 2025. Change in 30 Days versus previous period

Investment in Hutchison China Meditech Shares from India has grown by 160.71% over the past 30 days, indicating increased transactional activity.

-32%

Period: Mar 18, 2025 to Apr 17, 2025. Change in 30 Days versus previous period

Search interest for Hutchison China Meditech Stock from India on INDmoney has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Hutchison China Meditech

Schroder Investment Management Group
1.62%
Allianz Asset Management AG
0.66%
UBS Group AG
0.22%
State Street Corp
0.20%
AIA Group Ltd
0.18%
M&G PLC
0.16%

Analyst Recommendation on Hutchison China Meditech

Rating

Trend

Buy

90%Buy

9%Hold

0%Sell

Based on 22 Wall street analysts offering stock ratings for Hutchison China Meditech(by analysts ranked 0 to 5 stars)

Analyst Forecast on Hutchison China Meditech Stock (HCM)

What analysts predicted

Upside of 92.08%

Target:

$26.43

Current:

$13.76

Insights on Hutchison China Meditech Stock (Ticker Symbol: HCM)

Price Movement
In the last 7 days, HCM stock has moved up by 4.8%
Increasing Revenue
Revenue is up for the last 5 quarters, 152.56M → 162.26M (in $), with an average increase of 1.5% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 12.90M → 5.96M (in $), with an average decrease of 26.9% per quarter
HCM vs HLN (1 yr)
In the last 1 year, Haleon Plc Spon Ads has given 24.5% return, outperforming this stock by 36.6%
Price to Sales
ForHCM every $1 of sales, investors are willing to pay $3.7, whereas for Haleon Plc Spon Ads, the investors are paying $4.2 for every $1 of sales.

Hutchison China Meditech Technicals Summary

Sell

Neutral

Buy

Hutchison China Meditech is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Hutchison China Meditech (HCM) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Hutchison China Meditech Limited	-15.08%	-34.26%	-16.01%	-20.94%	-30.95%
Haleon Plc Spon Ads	-2.41%	0.69%	24.97%	37.11%	37.11%
United Therapeutics Corporation	-10.67%	-22.59%	20.37%	54.79%	60.38%
Zoetis Inc.	-8.87%	-24.07%	-4.15%	-21.07%	15.21%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Hutchison China Meditech Limited	71.9	71.9	0.0	0.17	0.05	-0.02	NA	0.89
Haleon Plc Spon Ads	24.68	24.68	1.8	0.41	0.09	0.05	0.02	1.79
United Therapeutics Corporation	11.57	11.57	1.43	27.16	0.19	0.12	NA	143.74
Zoetis Inc.	26.83	26.83	2.64	6.09	0.51	0.15	0.01	10.64

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Hutchison China Meditech Limited	Buy	$2.5B	-30.95%	71.9	5.99%
Haleon Plc Spon Ads	Buy	$45.7B	37.11%	24.68	12.84%
United Therapeutics Corporation	Buy	$12.8B	60.38%	11.57	41.53%
Zoetis Inc.	Buy	$65.5B	15.21%	26.83	26.86%

About Hutchison China Meditech

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. The company offers Fruquintinib, a selective and potent oral inhibitor of vascular endothelial growth factor receptors for treatment of colorectal cancer (CRC), breast cancer, gastric cancer (GC), microsatellite stable-CRC endometrial cancer (EMC), non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), endometrial cancer (EMC); and Savolitinib, a potent and selective inhibitor of mesenchymal-epithelial transition receptor to treat NSCLC, papillary RCC, and GC. It also develops Surufatinib to trea pancreatic neuroendocrine tumor (NET), non pancreatic NET, and pancreatic ductal adenocarcinoma; Sovleplenib, to treat immune thrombocytopenic purpura and warm autoimmune hemolytic anemia; and Tazemetostat, a treatment for epithelioid sarcoma and follicular lymphoma; Fanregratinib that treats intrahepatic cholangiocarcinoma; and Ranosidenib, a novel dual-inhibitor of dehydrogenase-1 and isocitrate dehydrogenase-2 enzymes to treat acute myeloid leukemia (AML). In addition, the company is developing HMPL-760, which is in phase I and II clinical trial to treat relapsed and/or refractory diffuse large B cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, and other B-NHL; HMPL-506 to treat Mixed-lineage leukemia-rearrange/rearrangement and nucleophosmin 1-mutantAML. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., and Epizyme, Inc., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.

Organization	Hutchison China Meditech
Employees	1811
CEO	Dr. Wei-Guo Su B.Sc., Ph.D.
Industry	Health Technology

Management People of Hutchison China Meditech

Name	Title
Dr. Wei-Guo Su B.Sc., Ph.D.	CEO, Chief Scientific Officer & Executive Director
Mr. Chig Fung Cheng BEc, CA	CFO & Executive Director
Ms. Edith Shih BSE, C.S., CGP, EdM, FCIS, FCS, FCS(PE), M.A., P.E	Company Secretary & Non-Executive Director
Ms. Yiling Cui	Executive VP & Head of Operations
David Ng	Head of Investor Relations & Capital Strategies
Mr. Charles George Rupert Nixon	Group General Counsel
Mr. Kin Hung Lee M.B.A.	Senior Vice President of Corporate Management & Communications
Ms. Selina Zhang	Senior Vice President of Global Human Resources
Dr. Qingmei Wang Ph.D.	Executive Vice President of Business Development & Strategic Alliances
Dr. Zhenping Wu M.B.A, Ph.D.	Executive Vice President of Pharmaceutical Science & Manufacturing

Important FAQs about investing in HCM Stock from India :

What is Hutchison China Meditech share price today?

Hutchison China Meditech share price today stands at $13.76, Open: $13.78 ; Previous Close: $13.74 ; High: $13.98 ; Low: $13.73 ; 52 Week High: $21.92 ; 52 Week Low: $11.51.

The stock opens at $13.78, after a previous close of $13.74. The stock reached a daily high of $13.98 and a low of $13.73, with a 52-week high of $21.92 and a 52-week low of $11.51.

Can Indians buy Hutchison China Meditech shares?

Yes, Indians can invest in the Hutchison China Meditech (HCM) from India.

With INDmoney, you can buy Hutchison China Meditech at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Hutchison China Meditech at zero transaction cost.

How can I buy Hutchison China Meditech shares from India?

It is very easy to buy Hutchison China Meditech from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Hutchison China Meditech (HCM) be purchased?

Yes, you can buy fractional shares of Hutchison China Meditech with INDmoney app.

What are the documents required to start investing in Hutchison China Meditech stocks?

To start investing in Hutchison China Meditech, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.